Efficacy of acitretin for porokeratosis in a child with chronic cutaneous graft versus host disease

Research output: Contribution to journalArticlepeer-review

Abstract

Porokeratosis is a rare disorder of epidermal keratinization that is regarded as a precancerous. Recipients of hematopoietic stem cell transplantation (HSCT) have a greater risk of skin cancer; chronic graft versus host disease (GVHD) is an additional risk factor. A 16-year-old boy who had received HSCT for acute myelogenous leukemia was referred to us for sclerodermoid chronic cutaneous GVHD. Two years later, he developed disseminated porokeratosis with a few atypical lesions. Despite cryotherapy, numerous lesions of porokeratosis recurred rapidly. Acitretin resulted in good clinical response and reduced the rate of onset of new lesions.

Original languageEnglish
Pages (from-to)148-150
Number of pages3
JournalPediatric Dermatology
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 2013

ASJC Scopus subject areas

  • Dermatology
  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Efficacy of acitretin for porokeratosis in a child with chronic cutaneous graft versus host disease'. Together they form a unique fingerprint.

Cite this